MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Synucleinopathies"

  • 2016 International Congress

    ESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways

    T. Hasegawa, R. Oshima, K. Tamai, N. Sugeno, A. Kikuchi, J. Kobayashi, S. Yoshida, A. Takeda, N. Tanaka, M. Aoki (Sendai, Japan)

    Objective: Endosomal sorting required for transport (ESCRT) orchestrates endo-lysosomal soring of ubiquitinated proteins, multivesicular body formation. The aim of this study is to elucidate the…
  • 2016 International Congress

    Low cerebrospinal fluid 3,4-dihydroxyphenylacetic acid and 3,4-dihydroxyphenylglycol levels are biomarkers of Parkinsonian disorders, including PSP

    A. Stefani, C. Holmes, E. Olivola, Y. Sharabi, D. Goldstein (Rome, Italy)

    Objective: To assess whether Progressive Sopranuclear Palsy (PSP) patients show, in CSF an alteration of catecholamine metabolites. Background: It was reported previously that, consistent with…
  • 2016 International Congress

    Dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behaviour disorder

    R. De Marzi, K. Seppi, B. Högl, C. Müller, C. Scherfler, A. Stefani, A. Iranzo, E. Tolosa, J. Santamarìa, E. Gizewski, M. Schocke, C. Kremser, W. Poewe (Innsbruck, Austria)

    Objective: To assess the loss of dorsolateral nigral hypersensitivity (DNH), which seems to correspond to nigrosome-1, using susceptibility-weighted imaging (SWI) at 3.0 Tesla (T) in…
  • 2016 International Congress

    Alpha-synuclein aggregates of cardiac sympathetic nerves in synucleinopathies and in neurologically unimpaired subjects. Correlation with sympathetic denervation

    M. Carmona-Abellán, I. Marcilla, I. Martínez-Valbuena, T. Tuñón, R. Luquin-Piudo (Pamplona, Spain)

    Objective: To study the cardiac sympathetic innervation and its relationship with the incidence of alpha-synuclein deposits in heart tissue of synucleinopathies and asymptomatic control patients.…
  • 2016 International Congress

    Novel PET Tracers of alpha-synuclein for the diagnosis of Parkinson’s disease

    E. Tsika, A. Davranche, J. Molette, E. Gabellieri, S. Papin, S. Nampally, H. Kroth, D. Lowe, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

    Objective: The aim of our project is to develop small molecular weight compounds (Morphomers™) which bind selectively to alpha-synuclein (aSyn) aggregates, in order to generate…
  • 2016 International Congress

    Sleep disordered breathing in patients of Parkinson’s disease with REM sleep behavior disorder

    R. Yadav, N. Kamble, J. Saini, K. Kumar, P.K. Pal (Bangalore, India)

    Objective: This prospective study was done to study the frequency and pattern of sleep disordered breathing (SDB) in patients with PD with RBD. Background: Parkinson's…
  • 2016 International Congress

    Probable REM sleep behaviour disorder and detrusor overactivity in primary cervical dystonia- A case report

    S.L. Bhadran, M.G.J. Jacob, S. Kripal (Thrissur, India)

    Objective: To report two atypical associations of pRBD and DO we came across with a case of primary cervical dystonia. Background: RBD (REM sleep Behaviour…
  • 2016 International Congress

    Parkinson’s disease and the frequent reasons for emergency admission in Metropolitan Medical Center; a 2 year retrospective study

    C.L. Go, K.A. Wong (Manila, Philippines)

    Objective: To determine the frequent cause of hospitalization among adult patients with Parkinson's disease (PD) in our institution. Background: Parkinson's disease is the second most…
  • 2016 International Congress

    Colonic α-synuclein: A potential diagnostic biomarker in Parkinson’s disease

    C. Ruffmann, I. Poggiolini, N. Bengoa-Vergniory, F. Baig, M. Rolinski, J. Klein, M.T. Hu, R. Wade-Martins, J. Alegre-Abarrategui, L. Parkkinen (Oxford, United Kingdom)

    Objective: To validate detection of α-synuclein pathology in the gastrointestinal (GI) tract as a diagnostic marker of Parkinson's disease (PD). Background: α-synuclein (ASN) deposition in…
  • 2016 International Congress

    Unconventional chaperone inhibits alpha-synuclein amyloid formation by promoting off-pathway aggregation

    J. Bieschke, E. Illes-Toth, M. Shah, N. Wu, S. Verzini, P. Selenko, E. Wanker (Saint Louis, MO, USA)

    Objective: To find new potential druggable targets that prevent alpha-synuclein aggregation and toxicity in Parkinson's disease. Background: Alpha-synuclein (aS) is the primary protein deposited in…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley